fda compounding semaglutide warning letters november 2025 issued 25 to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA unleashes warning letters to

Other genes related to lipid metabolism and AD risk include TREM2, APOJ, PICALM, ABCA1, and ABCA7, all involved in lipid transport

Furthermore, the antibody also demonstrated an effect of reducing fat mass (including both subcutaneous and visceral fat) without affecting lean body mass (primarily composed of muscle, bone, organs, blood, water, and other non-fat tissues)

The brain as a new metabolic target: a silent revolution Its fascinating to see how, quietly and without fanfare, incretin-based therapies are expanding their scope far beyond glycemic control

They also have a patient assistance program (CurAccess) that can lower costs by providing free home delivery to eligible patients